Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

3.56
Delayed Data
As of Sep 20
 +0.03 / +0.85%
Today’s Change
3.20
Today|||52-Week Range
10.04
-3.00%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Orbimed Advisors Llc
Director
Buy6/28/2019565,178$3.72$2.1M-4.81%
Orbimed Advisors Llc
Director
Buy6/28/2019565,178$3.72$2.1M-4.81%
Orbimed Advisors Llc
Director
Buy7/01/201959,243$3.91$231.6K-14.22%
Orbimed Advisors Llc
Director
Buy7/01/201959,243$3.91$231.6K-14.22%
Orbimed Advisors Llc
Director
Buy6/27/201932,923$3.34$110.0K+5.01%
Orbimed Advisors Llc
Director
Buy6/27/201932,923$3.34$110.0K+5.01%
Lea Leiv
Chief Financial Officer
Buy12/21/201824,700$4.15$102.5K-13.59%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy12/27/201820,000$3.29$65.8K+8.21%
Lea Leiv
Chief Financial Officer
Buy6/06/201915,500$3.56$55.2K+4.09%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy6/14/201911,657$3.40$39.6K+5.33%
Page of 2